Your browser doesn't support javascript.
loading
CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners.
Söhngen, Christian; Thomas, David J; Skowron, Margaretha A; Bremmer, Felix; Eckstein, Markus; Stefanski, Anja; Driessen, Marc D; Wakileh, Gamal A; Stühler, Kai; Altevogt, Peter; Theodorescu, Dan; Klapdor, Rüdiger; Schambach, Axel; Nettersheim, Daniel.
Afiliación
  • Söhngen C; Department of Urology, Urological Research Laboratory, Translational UroOncology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany.
  • Thomas DJ; Department of Urology, Urological Research Laboratory, Translational UroOncology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany.
  • Skowron MA; Department of Urology, Urological Research Laboratory, Translational UroOncology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany.
  • Bremmer F; Institute of Pathology, University Medical Center Goettingen, Germany.
  • Eckstein M; Institute of Pathology, Friedrich Alexander University Erlangen-Nürnberg, University Hospital, Germany.
  • Stefanski A; Molecular Proteomics Laboratory, Heinrich-Heine-University Düsseldorf, Germany.
  • Driessen MD; Molecular Proteomics Laboratory, Heinrich-Heine-University Düsseldorf, Germany.
  • Wakileh GA; Department of Urology, Urological Research Laboratory, Translational UroOncology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany.
  • Stühler K; Department of Urology, University Hospital Ulm, Germany.
  • Altevogt P; Molecular Proteomics Laboratory, Heinrich-Heine-University Düsseldorf, Germany.
  • Theodorescu D; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Klapdor R; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University Heidelberg, Germany.
  • Schambach A; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Nettersheim D; Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
FEBS J ; 290(20): 4864-4876, 2023 10.
Article en En | MEDLINE | ID: mdl-37254618
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Urogenitales / Receptores Quiméricos de Antígenos Tipo de estudio: Diagnostic_studies Límite: Humans / Male Idioma: En Revista: FEBS J Asunto de la revista: BIOQUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Urogenitales / Receptores Quiméricos de Antígenos Tipo de estudio: Diagnostic_studies Límite: Humans / Male Idioma: En Revista: FEBS J Asunto de la revista: BIOQUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Alemania